Daratumumab Single Agent and Daratumumab Plus Pomalidomide and Dexametasone in Relapsed/Refractory Multiple Myeloma: A Real Life Retrospective Evaluation
暂无分享,去创建一个
G. Morgan | A. Branca | L. Suva | M. Zangari | F. Davies | N. Weinhold | L. Rasche | D. Yoon | F. Rhee | S. Thanendrarajan | C. Schinke | Amy Buros | M. Mohan | C. Harcourt